Watkinson J C, Lazarus C R, Maisey M N, Clarke S E
Department of Otolaryngology, Guy's Hospital, London, UK.
Nucl Med Commun. 1990 Apr;11(4):313-7. doi: 10.1097/00006231-199004000-00009.
Technetium-99m (99Tcm) (v) dimercaptosuccinic acid (DMSA) is a new tumour imaging agent which has been used to evaluate head and neck tumours. It has a normal head and neck biodistribution to include the lacrimal glands, nasal mucosa and the blood-pool. Seventy-seven patients were studied of whom 63 had a head and neck malignancy. Of these patients, 19 (25%) exhibited positive accumulation of radioactivity in the region of the pituitary gland and this was a constant finding in those followed-up after treatment. Biodistribution studies in forty New Zealand white rabbits confirmed pituitary accumulation of 99Tcm (v) DMSA. The pituitary gland region should be included in the normal biodistribution of 99Tcm (v) DMSA.
锝-99m(99Tcm)(Ⅴ)二巯基丁二酸(DMSA)是一种新型肿瘤显像剂,已用于评估头颈部肿瘤。它在头颈部有正常的生物分布,包括泪腺、鼻黏膜和血池。对77例患者进行了研究,其中63例患有头颈部恶性肿瘤。在这些患者中,19例(25%)在垂体区域出现放射性阳性聚集,且这在治疗后随访的患者中是一个持续存在的发现。对40只新西兰白兔进行的生物分布研究证实了99Tcm(Ⅴ)DMSA在垂体的聚集。垂体区域应纳入99Tcm(Ⅴ)DMSA的正常生物分布中。